Related Experiment Videos
Norepinephrine storage, distribution, and release in diabetic cardiomyopathy
The American Journal of Physiology
|June 1, 1987
Summary
Diabetic rat hearts store more norepinephrine (NE) due to increased uptake and release. Insulin treatment reversed these changes, suggesting increased sympathetic activity in diabetic cardiomyopathy.
Area of Science:
- Cardiovascular Physiology
- Endocrinology
- Neuropharmacology
Background:
- Diabetes mellitus is associated with cardiac dysfunction.
- Alterations in cardiac autonomic function are observed in diabetic cardiomyopathy.
Purpose of the Study:
- To investigate the storage, distribution, and release of norepinephrine (NE) in the hearts of diabetic rats.
- To understand the role of NE in diabetic cardiomyopathy and the effects of insulin treatment.
Main Methods:
- Induction of diabetes in rats using streptozotocin.
- Measurement of NE content and concentration in cardiac and other tissues.
- Assessment of NE depletion following reserpine and tyramine administration.
- Evaluation of [3H]NE uptake, distribution, and release in isolated perfused hearts.
- Reversibility studies upon insulin treatment.
Main Results:
- Diabetic rats exhibited increased cardiac and tissue NE content and concentration.
- Diabetic hearts showed greater NE depletion with reserpine and altered sensitivity to tyramine.
- Enhanced [3H]NE uptake and accelerated spontaneous release were observed in diabetic hearts.
- Insulin treatment reversed the observed alterations in cardiac NE handling.
Conclusions:
- Sympathetic activity is increased in diabetic cardiomyopathy.
- Elevated cardiac NE levels in diabetic rats are partly due to increased NE reuptake by adrenergic nerve terminals.
- These changes are reversible with insulin therapy, highlighting the metabolic link.